Less Ads, More Data, More Tools Register for FREE

Pin to quick pickseEnergy Group Regulatory News (EAAS)

Share Price Information for eEnergy Group (EAAS)

Share Price is delayed by 15 minutes
Get Live Data
5.05    0.00 (0.00%)
Bid:
4.80
Ask:
5.30
Spread: 0.50 (10.417%)
Market Cap: £19.55m
EAAS Live PriceLast checked at - London Stock Exchange

Intraday eEnergy Group Share Chart

Research and Development Update

24 Jan 2018 07:56

RNS Number : 7628C
Alexander Mining PLC
24 January 2018
 

24 January 2018

Alexander Mining plc

("Alexander" or the "Company")

Research and Development Update

 

Alexander is pleased to provide an update on its research and development activities.

 

HyperLeach®

Alexander has committed to funding a preliminary study into the use of its proprietary HyperLeach® process for the potential recovery of high-purity nickel and cobalt salts from nickel flotation tailings. The consensus forecast is for increases in demand for electric vehicles and energy storage solutions which will require significant several fold increases of 'Class 1' nickel and cobalt supply over current levels of production from global resources. The uncertainty surrounding the long-term stability of the Democratic Republic of the Congo has opened up the cobalt market to other supply opportunities. The need to be in production in the short to medium-term to meet the predicted demand is an additional driving force for the reprocessing of existing, readily mined surficial resources.

HyperLeach® also has the potential to process ore or concentrate at the mine site producing a range of products. There is the additional potential to lower the cut-off grade at producing mines by giving greater return at the mine gate through the production of higher-value products instead of concentrates.

Alexander's CEO, Martin Rosser, said "This project offers Alexander the opportunity to gain extremely valuable information on the treatment of the nickel-cobalt bearing tailings produced by a sulphide flotation plant. The potential production of high-purity salts via HyperLeach® would be an excellent outcome and, if successful, it would give the Company an exciting opportunity to be able to produce battery grade nickel and cobalt salts in the medium-term." 

This initiative is the most recent part of Alexander's longer-term strategic involvement in energy metals, notably lithium, nickel, cobalt, copper and vanadium.

Lithium - research and development joint venture

The initial results from the joint venture with Alexander's Principal Technical Consultant, Dr. Nicholas Welham, on lithium heap leaching from hard rock resources have been delayed due to procedural issues beyond Alexander's control.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. 

 

ENDS

For further information, please contact:

 

Martin Rosser

Chief Executive

Mobile: +44 (0) 7770 865 341

 

 

Alan Clegg

Non-Executive Chairman

Mobile: +90 543 533 0665

 

 

Alexander Mining plc

Tel: +44 (0) 20 7078 9566

Email: mail@alexandermining.com

Website: www.alexandermining.com

 

 

Northland Capital Partners Limited 

Matthew Johnson / Gerry Beaney

(Corporate Finance)

John Howes

(Corporate Broking)

Tel: +44 (0) 20 3861 6625

 

 

Turner Pope Investments (TPI) Ltd

Andy Thacker

Tel: +44 (0) 20 3621 4120

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDUSVBRWOAAURR
Date   Source Headline
1st Jun 20267:00 amRNSPublication of AR, Notice of AGM and Board Update
18th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSBoard changes
30th Apr 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
16th Apr 20267:00 amRNSQ1 Trading Update, Revenue Recognition & Outlook
4th Mar 20267:00 amRNS-RContract wins
23rd Feb 20267:00 amRNSLoan Agreement
23rd Jan 20267:00 amRNSTrading Update
22nd Jan 20267:00 amRNSLaunch of new funding solution and first contract
19th Jan 20267:00 amRNSAppointment of Non-Executive Director
15th Dec 20257:00 amRNSFY Trading Update
27th Nov 20257:00 amRNSDirectorate change
17th Nov 20253:20 pmRNSAward of Options
12th Nov 20254:38 pmRNSSolar Agreement, Loan Agreement, Grant of Warrants
29th Oct 202511:39 amRNSHolding(s) in Company
27th Oct 20257:00 amRNS-RLargest EV Charging Project to Date with NHS
23rd Oct 20252:10 pmRNSHolding(s) in Company
20th Oct 20251:28 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSPreferred supplier for major solar contract
22nd Aug 20253:04 pmRNSHolding(s) in Company
21st Aug 20253:09 pmRNSHolding(s) in Company
19th Aug 202510:50 amRNSHolding(s) in Company
7th Aug 202512:13 pmRNSHolding(s) in Company
31st Jul 20255:17 pmRNSResult of AGM
22nd Jul 20257:00 amRNSUnaudited HY Results - Six Months Ended 30.06.25
3rd Jul 202510:46 amRNSNotice of AGM
30th Jun 20257:00 amRNSNotice of Results
13th Jun 20259:30 amRNSNotice of FY Results and Investor Presentation
3rd Jun 20259:25 amRNSHolding(s) in Company
20th May 202511:10 amRNSHolding(s) in Company
16th May 20257:00 amRNS£100m Partnership with Redaptive
7th Apr 20257:00 amRNS-RFramework win
26th Mar 20257:00 amRNS-RLaunch of SolarLife
24th Mar 20257:00 amRNS-RContracts wins and appointment to a Framework
11th Mar 20257:00 amRNS-RContract Wins
12th Feb 202511:17 amRNSHolding(s) in Company
3rd Feb 20257:00 amRNS-RInvestor Meet Company Presentation
30th Jan 20257:00 amRNSTrading update
19th Dec 20241:45 pmRNSAward of Options and PDMR Transactions
28th Nov 20247:00 amRNS-RLED Conversion Contract in Further Education
15th Oct 202410:45 amRNSHolding(s) in Company
1st Oct 20247:00 amRNSDirector appointment - additional information
30th Sep 20247:00 amRNSResults for the six months ended 30 June 2024
6th Sep 20247:00 amRNSHolding(s) in Company
8th Aug 20247:00 amRNSInvestor Presentations
26th Jul 20247:00 amRNSH1 24 Trading Update
28th Jun 20243:03 pmRNSResult of AGM
13th Jun 20247:00 amRNSNotice of General Meeting
30th Apr 20247:01 amRNSFinal Results for the 18 months ended 31 Dec 2023
22nd Apr 20247:00 amRNSMajor Contract Win with Spire Healthcare

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.